Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 7/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 7/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2539347 | 1.00 | PARP1 (0.40) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL13557473 | 1.00 | PARP1 (0.40) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL2543825 | 1.00 | PARP1 (0.40) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL9063186 | 0.97 | MAPT (0.43) | PARP1MAPTPDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL5238010 | 0.97 | PARP1 (0.39) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL11835522 | 0.97 | PARP1 (0.39) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL11091560 | 0.97 | PARP1 (0.39) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL6219549 | 0.94 | PARP1 (0.36) | PARP1MAPTPDE4APDE4BPDE4C | |
| SCHEMBL12428067 | 0.94 | PARP1 (0.36) | PARP1MAPTPDE4APDE4BPDE4C | |
| Phosphoric Acid SCHEMBL5328897 | 0.87 | PARP1 (0.35) | PARP1MAPTPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 737 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4206205-B1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE BEIJING CO LTD (CN) | 2026-03-04 | — | — | EP | claimed |
| WO-2024213237-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2024-10-17 | — | — | WO | claimed |
| CN-114616229-B | Tricyclic compounds and pharmaceutical uses thereof | 镇斗生物科技股份公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118496072-A | Method for preparing 2-butanone by biomimetic catalytic oxidation of n-butane | 浙江工业大学 | 2024-08-16 | — | — | CN | claimed |
| CN-118146084-A | Method for preparing benzoic acid and coproducing epsilon-caprolactone by biomimetically catalyzing air to oxidize toluene and cyclohexanone | 广西大学 | 2024-06-07 | — | — | CN | claimed |
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE (BEIJING) CO., LTD. (CN) | 2023-09-28 | — | — | US | claimed |
| CN-116651362-A | Cis hexahydrophthalimide preparation device | 濮阳市盛源能源科技股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| EP-4206205-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | Primegene (Beijing) Co., Ltd. (CN) | 2023-07-05 | — | — | EP | claimed |
| CN-109923711-B | Binder composition for lithium battery | 富士胶片和光纯药株式会社 | 2023-06-27 | — | — | CN | claimed |
| CN-109937500-B | Binder composition for lithium battery electrode and electrode using same | 富士胶片和光纯药株式会社 | 2023-04-11 | — | — | CN | claimed |
| WO-1987007602-A2 | N-(5-SUBSTITUTED METHYLENE) PHENYL HERBICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1987-12-17 | — | — | WO | claimed |
| EP-0109562-B1 | SUCCINIMIDE DERIVATIVES AND THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-02 | — | — | EP | claimed |
| EP-0214112-A2 | Polyester compositions containing phthalimidoesters | Monsanto Company (US) | 1987-03-11 | — | — | EP | claimed |
| US-4469874-A | ALKYL THIOSALICYLATES | MONSANTO COMPANY (US) | 1984-09-04 | — | — | US | claimed |
| US-4283508-A | Fragrant prevulcanization inhibitors | MONSANTO COMPANY (US) | 1981-08-11 | — | — | US | claimed |
| US-4148845-A | OIL ADDITIVES | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1979-04-10 | — | — | US | claimed |
| US-4139417-A | Lubricating oil compositions containing copolymers of olefins or of olefins and non-conjugated dienes with unsaturated derivatives of cyclic imides | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1979-02-13 | — | — | US | claimed |
| US-4063010-A | LUBRICANT ADDITIVES | SOCIETE NATIONALE ELF AQUITAINE (SNEA) (FR) | 1977-12-13 | — | — | US | claimed |
| US-3987056-A | DISPROPORTIONATION OF N-ARYL-1,2,3,6-TETRAHYDROPHTHALIMIDES | PHILLIPS PETROLEUM COMPANY (US) | 1976-10-19 | — | — | US | claimed |
| US-3956241-A | CHROMIUM(III) CHELATE COMPOUND | AEROJET-GENERAL CORPORATION (US) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | DPYD, RPLP2, DHPS | PARP1 624/4885MAPT 3577/4885PDE4A 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.